|
1
|
Organization WHO: The top 10 causes of
death. Journal. 2014.
|
|
2
|
Gonzalez SA: Novel biomarkers for
hepatocellular carcinoma surveillance: Has the future arrived?
Hepatobiliary Surg Nutr. 3:410–414. 2014.
|
|
3
|
Baird A, Lee J, Podvin S, Kurabi A, Dang
X, Coimbra R, Costantini T, Bansal V and Eliceiri BP: Esophageal
cancer-related gene 4 at the interface of injury, inflammation,
infection, and malignancy. Gastrointest Cancer. 2014:131–142. 2014.
View Article : Google Scholar
|
|
4
|
Capece D, Fischietti M, Verzella D,
Gaggiano A, Cicciarelli G, Tessitore A, Zazzeroni F and Alesse E:
The inflammatory micro-environment in hepatocellular carcinoma: A
pivotal role for tumor-associated macrophages. Biomed Res Int.
2013:1872042013. View Article : Google Scholar
|
|
5
|
Bharadwaj S and Gohel TD: Perspectives of
physicians regarding screening patients at risk of hepatocellular
carcinoma. Gastroenterol Rep (Oxf) gou089. 2015.
|
|
6
|
Salhab M and Canelo R: An overview of
evidence-based management of hepatocellular carcinoma: A
meta-analysis. J Cancer Res Ther. 7:463–475. 2011. View Article : Google Scholar
|
|
7
|
Almeida JRCd: Farmacêuticos em Oncologia:
uma nova realidade. Atheneu; Aracaju: pp. 3582004, In
Portuguese.
|
|
8
|
Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang
XW and Tang ZY: Effect of rapamycin alone and in combination with
sorafenib in an orthotopic model of human hepatocellular carcinoma.
Clin Cancer Res. 14:5124–5130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Zhou J, Fan J, Tan CJ, Qiu SJ, Yu
Y, Huang XW and Tang ZY: Sirolimus inhibits the growth and
metastatic progression of hepatocellular carcinoma. J Cancer Res
Clin Oncol. 135:715–722. 2009. View Article : Google Scholar
|
|
10
|
Wang C, Gao D, Guo K, Kang X, Jiang K, Sun
C, Li Y, Sun L, Shu H, Jin G, et al: Novel synergistic antitumor
effects of rapamycin with bortezomib on hepatocellular carcinoma
cells and orthotopic tumor model. BMC Cancer. 12:1662012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Speeg KV, Washburn WK and Halff G:
Sirolimus plus sorafenib in treating HCC recurrence after liver
transplantation: A case report. World J Gastroenterol.
16:5518–5522. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J: 203985 Everolimus Clinpharm BPCA.
2012, http://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm320466.pdf.
Accessed February 11, 2016.
|
|
13
|
Zirkelbach JF: 22088 Temsirolimus
Clinpharm BPCA. 2011, http://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm307049.pdf.
Accessed February 11, 2016.
|
|
14
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR Signaling in Cancer. Front Oncol. 4:642014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sahin F, Kannangai R, Adegbola O, Wang J,
Su G and Torbenson M: mTOR and P70 S6 kinase expression in primary
liver neoplasms. Clin Cancer Res. 10:8421–8425. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cuconati A, Mills C, Goddard C, Zhang X,
Yu W, Guo H, Xu X and Block TM: Suppression of AKT anti-apoptotic
signaling by a novel drug candidate results in growth arrest and
apoptosis of hepatocellular carcinoma cells. PLoS One.
8:e545952013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cendales L, Bray R, Gebel H, Brewster L,
Elbein R, Farthing D, Song M, Parker D, Stillman A, Pearson T, et
al: Tacrolimus to belatacept conversion following hand
transplantation: A case report. Am J Transplant. 15:2250–2255.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seok SM, Park TY, Park HS, Baik EJ and Lee
SH: Fructose-1,6-bisphosphate suppresses lipopolysaccharide-induced
expression of ICAM-1 through modulation of toll-like receptor-4
signaling in brain endothelial cells. Int Immunopharmacol.
26:203–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang JF, Liu JJ, Lu MQ, Cai CJ, Yang Y,
Li H, Xu C and Chen GH: Rapamycin inhibits cell growth by induction
of apoptosis on hepatocellular carcinoma cells in vitro. Transpl
Immunol. 17:162–168. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai ZJ, Gao J, Ma XB, Kang HF, Wang BF, Lu
WF, Lin S, Wang XJ and Wu WY: Antitumor effects of rapamycin in
pancreatic cancer cells by inducing apoptosis and autophagy. Int J
Mol Sci. 14:273–285. 2012. View Article : Google Scholar
|
|
21
|
Philipp AB, Nagel D, Stieber P, Lamerz R,
Thalhammer I, Herbst A and Kolligs FT: Circulating cell-free
methylated DNA and lactate dehydrogenase release in colorectal
cancer. BMC Cancer. 14:2452014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Human Inflammatory Cytokines Kit
Instruction Manual. Journal. 2008, http://www.bdbiosciences.com/documents/CBA_Human_Inf_Cytokine_manual.pdf.
Accessed February 11, 2016.
|
|
23
|
Kim TM, Shin SK, Kim TW, Youm SY, Kim DJ
and Ahn B: Elm tree bark extract inhibits HepG2 hepatic cancer cell
growth via pro-apoptotic activity. J Vet Sci. 13:7–13. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiela ECF: Protocol for measuring
autophagy. Journal. http://www.ufrgs.br/labsinal/autofagia.htm.
Accessed February 11, 2016.
|
|
25
|
Nepal S and Park PH: Regulatory role of
autophagy in globular adiponectin-induced apoptosis in cancer
cells. Biomol Ther (Seoul). 22:384–389. 2014. View Article : Google Scholar
|
|
26
|
Carlos SP, Dias AS, Forgiarini Júnior LA,
Patricio PD, Graciano T, Nesi RT, Valença S, Chiappa AM, Cipriano G
JR, Souza CT, et al: Oxidative damage induced by cigarette smoke
exposure in mice: impact on lung tissue and diaphragm muscle. J
Bras Pneumol. 40:411–420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rutkowski MR and Conejo-Garcia JR: Size
does not matter: Commensal microorganisms forge tumor-promoting
inflammation and anti-tumor immunity. Oncoscience. 2:239–246. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Asnaghi L, Bruno P, Priulla M and Nicolin
A: mTOR: A protein kinase switching between life and death.
Pharmacol Res. 50:545–549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McGranahan N, Favero F, De Bruin EC,
Birkbak NJ, Szallasi Z and Swanton C: Clonal status of actionable
driver events and the timing of mutational processes in cancer
evolution. Sci Transl Med. 7:283ra542015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fervenza FC, Fitzpatrick PM, Mertz J,
Erickson SB, Liggett S, Popham S, Wochos DN, Synhavsky A, Hippler
S, Larson TS, et al Mayo Nephrology Collaborative Committee: Acute
rapamycin nephrotoxicity in native kidneys of patients with chronic
glomerulopathies. Nephrol Dial Transplant. 19:1288–1292. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Azambuja AA, Lunardelli A, Nunes FB,
Gaspareto PB, Donadio MV, Poli de Figueiredo CE and de Oliveira JR:
Effect of fructose-1,6-bisphosphate on the nephrotoxicity induced
by cisplatin in rats. Inflammation. 34:67–71. 2011. View Article : Google Scholar
|
|
32
|
Seelaender M, Neto JC, Pimentel GD,
Goldszmid RS and Lira FS: Inflammation in the disease: Mechanism
and therapies 2014. Mediators Inflamm. 2015:1698522015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raza H, John A and Benedict S:
Acetylsalicylic acid-induced oxidative stress, cell cycle arrest,
apoptosis and mitochondrial dysfunction in human hepatoma HepG2
cells. Eur J Pharmacol. 668:15–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Goswami B, Rajappa M, Mallika V, Shukla DK
and Kumar S: TNF-alpha/IL-10 ratio and C-reactive protein as
markers of the inflammatory response in CAD-prone North Indian
patients with acute myocardial infarction. Clin Chim Acta.
408:14–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raouf S, Weston C and Yucel N:
Reproducibility Project: Cancer Biology: Registered report:
Senescence surveillance of pre-malignant hepatocytes limits liver
cancer development. Elife. Jan 26–2015. View Article : Google Scholar
|
|
36
|
Vessoni AT, Filippi-Chiela EC, Menck CF
and Lenz G: Autophagy and genomic integrity. Cell Death differ.
20:1444–1454. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Suzuki K and Matsubara H: Recent advances
in p53 research and cancer treatment. J BioMed Biotechnol.
2011:9783122011. View Article : Google Scholar : PubMed/NCBI
|
